EU and response to cross-border health threats in the light of the COVID-19 pandemic
Authors:
J. Malíř 1; M. Svobodová 2
Authors place of work:
Ústav státu a práva AV ČR, v. v. i., Praha, Oddělení veřejného práva, Ředitel: JUDr. Ján Matejka, Ph. D.
1; Univerzita Karlova v Praze, Právnická fakulta, Katedra evropského práva, Vedoucí: prof. JUDr. PhDr. Michal Tomášek, DrSc.
2
Published in the journal:
Prakt. Lék. 2021; 101(6): 201-308
Category:
Reviews
Summary
The COVID-19 pandemic has posed challenges not only with respect to states but also to international organisations, including the European Union (EU). In the present article, the authors focus precisely on the case of the EU. They provide an overview of powers which the EU possesses in the area of public health and they also present the recent proposals which aim at establishing the European Health Union or at better coordinating free movement of persons and goods upon the EU level. The pandemic has pointed to series of shortcomings in the functioning of the present EU system the purpose of which is to eliminate the serious cross-border threats to health. At the same time, however, the pandemic has demonstrated the importance which the cooperation between states, their mutual solidarity and the support from the EU have with regard to combatting serious cross-border health threats.
Keywords:
European Union – public health – COVID-19 – powers – European Health Union – free movement of persons and goods
Zdroje
1. Tomášek M, Týč V, Petrlík D, a kol. Právo Evropské unie. Praha: Leges 2021; 125–126.
2. Tomášek M, Týč V, Petrlík D, a kol. Právo Evropské unie. Praha: Leges 2021; 126–127.
3. Priollaud F-X, Siritzky D. Le traité de Lisbonne. Textes et commentaires, Paris: La Documentation française 2008; 279 –280.
4. Klamert M. Public health policy. In: Hofmann H, Rowe GC, Turk AH (eds.) Specialized administrative law of the European Union. A Sectoral Review. Oxford: Oxford University Press 2019; 405–407.
5. Bengtsson L, Rhinard M. Securitisation across borders: the case of ‘health security’ cooperation in the European Union. West European Politics 2019; 42(2): 346–368.
6. Blanc D. Unis dans l’adversité: la protection civile de l’Union, instrument d’une solidarité éprouvée par le coronavirus. Revue de l’Union européenne 2020; 638: 270–276.
7. Haussig J M, Severi E, Baum J, et al. The European medical corps: first public health team mission and future perspectives. Euro Surveill 2017; 22(37): 30613.
8. Pooter H. de. La passation conjointe des marchés de contre-mesures médicales dans le contexte de la pandémie COVID-19. Europe 2020; 5: 8–13.
9. Davesne A, Guigner S. La Communauté européenne de la santé (1952–1954). Une redécouverte intergouvernementaliste du projet fonctionnaliste de „pool blanc“. Politique européenne 2013; 3(41): 40–63.
10. Hofmann H, Rowe GC, Turk AH. Synthesis and Assessment. In: Hofmann H, Rowe GC, Turk AH. (Eds.). Specialized administrative law of the European Union. A Sectoral Review. Oxford: Oxford University Press 2019; 633–634.
11. Kochenov DV, Veraldi JD. The Commission against the internal market and European Union citizens’ rights: trying to shoot down Sputnik with the “Digital Green Certificate”? Eur J Risk Regul 2021; 12(2): 404–414.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2021 Číslo 6
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Quality of life of patients after orthotopic liver transplantation performed for alcoholic cirrhosis
- Can GPs ease the plight of informal carers?
- Specifics of evidence-based practice guidelines for public health domain and proposal of an algorithm for their development and evaluation
- Mesenchymal stem cells business – importance of informed consent